1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Biotrial: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2) - Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | Unknown | Sqy Therapeutics | 12 | 2023-04-26 | 2024-04-01 |
| Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours EXS21546 - Advanced Solid Tumours | Phase 1 / Phase 2 | Terminated | Exscientia AI Limited | 6 | 2023-04-11 | 2023-11-08 |
Muscular Dystrophy, Duchenne (1)
Clinical Trials, Phase I as Topic (1)
France (2) · Belgium (1)